Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about 13 Open Access Articles, 35 Conference Proceedings, 26 Speakers, 2 Editors PPTs, 2 National symposiums, 6 Useful Links related to Adjuvant therapy.
Adjuvant therapy or additional cancer treatment given after the primary cancer treatment to lower the risk of cancer to come back. It is done after primary treatments like surgery or radiation. Cancer treatments that are used as adjuvant therapies include: Chemotherapy, Hormone therapy, Radiation therapy, Immuno therapy, Targeted therapy. Treating certain types of cancers like breast cancer and colon cancer with adjuvant therapy is beneficial. Certain cancers may have specific changes within their cells that indicate the chances of cancer to return. If tests show cancer is unlikely to recur, adjuvant therapy may offer benefit. A cancer's stage refers to the extent of the cancer.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Additional cancer treatment given after the primary treatment to lower the risk that the cancer will come back. Adjuvant therapy may include chemotherapy, radiation therapy, hormone therapy, targeted therapy, or biological therapy. It is a perfect platform to discuss the current discoveries and developments in the field of adjuvant therapy.
As an adjuvant agent modifies the effect of another agent, so adjuvant therapy modifies other therapy. The surgeries and complex treatment regimens used in cancer therapy have led the term to be used mainly to describe adjuvant cancer treatments. An example of such adjuvant therapy is the additional treatment usually given after surgery where all detectable disease has been removed, but where there remains a statistical risk of relapse due to occult disease.
Adjuvant therapy conference aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of:
1. Breast cancer
2. Brain cancer
3. Lung cancer
It also provides the platform for researchers, scholars and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Respiratory disease. The recent research in Oncology shares knowledge to scholars pursing their studies in this field.
The major aim of giving adjuvant therapy to cancer patients is to increase the chance of overall survival of such patient. Since the rationale behind adjuvant therapy is elimination of future risk, the accepted rule is that the patients were already cured via primary surgical treatment. Thus, such therapies given after an oncological surgery for different types of cancers such as that of lung, breast, colon, prostate, and various forms of gynecological cancers. Adjuvant therapy is often given after oncology surgery the treatment procedure of illnesses such as colon cancer, pancreatic cancer, gynecological cancer, breast cancer, lung cancer, and prostate cancer. However, some forms of cancer such as renal carcinoma and some types of brain cancer have failed to benefit from such a therapy.
The overall market for oncology adjuvants is classified on the basis of applications of adjuvants such as chemotherapy, radiotherapy, immunotherapy and others. On the basis of diseases which are treated through adjuvants, this market is classified into breast cancer, colorectal cancer, sarcoma, Hodgkin’s lymphoma, glioblastoma, lung cancer, prostate cancer, and ovarian cancer.
International symposium and workshops
1. WCLC 2015 — 16th World Conference on Lung Cancer,
06 Sep 2015 → 09 Sep 2015, Denver, United States
2. 3rd International Oncology Conference, 10 Sep 2015-11 Sep 2015
Abu Dhabi, United Arab Emirates
3. From Tumor Suppressors to Oncogenic Dynamics:The 2015 Dr. Paul Janssen Award
Symposium16, Sep 2015 New York, United States
1. Conference on Cervical Cancer September 22-23, 2016 Vienna, Austria
2. Conference and Exhibition on Pediatric Oncology
August 04-06, 2016 Toronto, Canada
3. Experts Meeting on Gynecologic Oncology May 19-21, 2016 San Antonio, USA
4. 8th Euro Global Summit on Cancer Therapy November 03-05, 2015 Valencia, Spain
6. Conference on Mesothelioma November 03-04, 2016 Valencia, Spain
7. Conference and Exhibition on Surgical Oncology
September 01-03, 2016 Sao Paulo, Brazil
9. 11th Asia-Pacific Oncologists Annual Meeting
July 11-13,2016 Kuala Lumpur, Malaysia
11. 7th Global Summit on Cancer Therapy October 05-07, 2015 Dubai, UAE
12. Hypertension Conference, August 04-06, 2016 Toronto, Canada
13. Anatomy & Physiology Conference, August 11-13, 2016 Birmingham, UK
14. 8th Cancer Therapy Conference, November 03-05, 2015 Valencia, Spain
Relevant Society and Associations
1. American Society of Clinical Oncology
2. Canadian Cancer Society
3. American Association for Cancer Research
4. American Brain Tumor Association
5. American Society for Therapeutic Radiology and Oncology
6. American Society of Pediatric Hematology/Oncology
7. American Thoracic Society
8. Association for Molecular Pathology
9. Association of Cancer Online Resources (ACOR)
10. Association of Community Cancer Centers
11. Brain Tumor Society
12. Cancer Research Institute
13. Candlelighters Childhood Cancer Foundation (USA)
14. Eastern Cooperative Oncology Group (ECOG)
15. European society of critical care medicine
16. Indian society of critical care medicine
17. Michigan State Medical Society
18. National Alliance of Breast Cancer Organizations (NABCO)
19. North American Association of Central Cancer Registries
20. Radiation Therapy Oncology Group
4. Johnson & Johnson
5. Bristol-Myers Squibb
9. Merck & Co.
16. Merck KGaA
This page will be updated regularly.
This page was last updated on February 21, 2020